» Articles » PMID: 28008423

Gene Splice Mutations Cause Dilated Cardiomyopathy

Abstract

Objective: To identify novel dilated cardiomyopathy (DCM) causing genes, and to elucidate the pathological mechanism leading to DCM by utilizing zebrafish as a model organism.

Background: DCM, a major cause of heart failure, is frequently familial and caused by a genetic defect. However, only 50% of DCM cases can be attributed to a known DCM gene variant, motivating the ongoing search for novel disease genes.

Methods: We performed whole exome sequencing (WES) in two multigenerational Italian families and one US family with arrhythmogenic DCM without skeletal muscle defects, in whom prior genetic testing had been unrevealing. Pathogenic variants were sought by a combination of bioinformatic filtering and cosegregation testing among affected individuals within the families. We performed function assays and generated a zebrafish morpholino knockdown model.

Results: A novel filamin C gene splicing variant ( c.7251+1 G>A) was identified by WES in all affected family members in the two Italian families. A separate novel splicing mutation ( c.5669-1delG) was identified in the US family. Western blot analysis of cardiac heart tissue from an affected individual showed decreased protein, supporting a haploinsufficiency model of pathogenesis. To further analyze this model, a morpholino knockdown of the ortholog filamin Cb in zebrafish was created which resulted in abnormal cardiac function and ultrastructure.

Conclusions: Using WES, we identified two novel splicing variants as the likely cause of DCM in three families. We provided protein expression and zebrafish data supporting haploinsufficiency as the pathogenic mechanism leading to DCM.

Citing Articles

Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants.

Gigli M, Stolfo D, Barbati G, Graw S, Chen S, Merlo M JAMA Cardiol. 2025; .

PMID: 39937464 PMC: 11822610. DOI: 10.1001/jamacardio.2024.5543.


Connecting intermediate phenotypes to disease using multi-omics in heart failure.

Moore A, Venkatesh R, Levin M, Damrauer S, Reza N, Cappola T Pac Symp Biocomput. 2024; 30:504-521.

PMID: 39670392 PMC: 11822568.


Gene Analysis of Four Families with Severe Peripartum Cardiomyopathy Reveals Known Gene Mutations and Supports the Recent Call for Screening.

Li M, Yin K, Chen L, Chang J, Hao N Rev Cardiovasc Med. 2024; 25(11):399.

PMID: 39618871 PMC: 11607517. DOI: 10.31083/j.rcm2511399.


Unveiling the Spectrum of Minor Genes in Cardiomyopathies: A Narrative Review.

Micolonghi C, Perrone F, Fabiani M, Caroselli S, Savio C, Pizzuti A Int J Mol Sci. 2024; 25(18).

PMID: 39337275 PMC: 11431948. DOI: 10.3390/ijms25189787.


Connecting intermediate phenotypes to disease using multi-omics in heart failure.

Moore A, Venkatesh R, Levin M, Damrauer S, Reza N, Cappola T medRxiv. 2024; .

PMID: 39148828 PMC: 11326335. DOI: 10.1101/2024.08.06.24311572.


References
1.
Parks S, Kushner J, Nauman D, Burgess D, Ludwigsen S, Peterson A . Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am Heart J. 2008; 156(1):161-9. PMC: 2527054. DOI: 10.1016/j.ahj.2008.01.026. View

2.
van der Flier A, Sonnenberg A . Structural and functional aspects of filamins. Biochim Biophys Acta. 2001; 1538(2-3):99-117. DOI: 10.1016/s0167-4889(01)00072-6. View

3.
Roncarati R, Viviani Anselmi C, Krawitz P, Lattanzi G, von Kodolitsch Y, Perrot A . Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy. Eur J Hum Genet. 2013; 21(10):1105-11. PMC: 3778353. DOI: 10.1038/ejhg.2013.16. View

4.
Burns C, Milan D, Grande E, Rottbauer W, MacRae C, Fishman M . High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat Chem Biol. 2006; 1(5):263-4. DOI: 10.1038/nchembio732. View

5.
Mestroni L, Maisch B, McKenna W, Schwartz K, Charron P, Rocco C . Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J. 1999; 20(2):93-102. DOI: 10.1053/euhj.1998.1145. View